# A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)

> **NCT00140881** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 220 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MK0476; montelukast sodium
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00140881
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06-01
- **Primary completion:** 2003-02-14
- **Final completion:** 2003-02-14
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140881, "A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00140881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*